Andere talen Mesoblast Limited

Aandelen

MSB

AU000000MSB8

Beurs gesloten - Australian S.E. Andere beurzen 08:10:45 26-04-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
0,93 ^AUD	+1,64%		+20,00%	+200,00%

26/03	FDA zegt dat gegevens van Mesoblast-studie voldoende zijn om BLA-indiening te ondersteunen	MT
26/03	Sectorupdate: Gezondheidszorgaandelen stijgen laat in de middag	MT

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

ADRs End Higher; Connect Biopharma Climbs 26%	01/04
ADRs End Lower; NuCana Slides 15%	28/03
Reddit Inc. (NYSE: RDDT) Surges, Uncovering Undervalued Opportunities: DYAI, INBS, MESO, VTAK	28/03
ADRs End Lower; Quhuo Drops 53%	26/03
FDA Says Mesoblast Trial Data Sufficient to Support BLA Submission	26/03
Sector Update: Health Care Stocks Advance Late Afternoon	26/03
Top Midday Gainers	26/03
Sector Update: Health Care Stocks Steady Premarket Tuesday	26/03
Wall Street Set to Open Modestly Higher Tuesday Ahead Consumer Confidence Reading	26/03
Top Premarket Gainers	26/03
Mesoblast Shares Jump After FDA Nod for Submission of Remestemcel-L Application	26/03
Mesoblast to Resubmit Application for Potential Pediatric Treatment of Graft Versus Host Disease; Shares Gain Pre-Bell	26/03
United States Food & Drug Administration (FDA) Notifies Mesoblast that Available Clinical Data from Phase 3 Trial Appear Sufficient to Support BLA Submission for Remestemcel-L in Children with Steroid-Refractory Acute Graft Versus Host Disease (SR-aGVHD)	26/03
United States Food & Drug Administration Notifies Mesoblast Limited of Available Clinical Data from Phase 3 Trial Appear Sufficient to Support BLA Submission for Remestemcel-L in Children with Steroid-Refractory Acute Graft Versus Host Disease	26/03
Mesoblast Limited(ASX:MSB) added to S&P/ASX Emerging Companies Index	18/03
Mesoblast Raises AU$97 Million From Entitlement Offer, Institutional Placement	14/03
Mesoblast Raises AU$97 Million for Phase Three Registration Trials	14/03
Mesoblast Successfully Completes Placement and Accelerated Entitlement Offer	14/03
Sector Update: Health Care Stocks Softer Late Afternoon	11/03
Sector Update: Health Care Stocks Decline in Afternoon Trading	11/03

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Mesoblast Limited

Aandelen

MSB

AU000000MSB8

Andere talen

Filters